Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Bayer/Evogene amend wheat research deal

Israeli plant genomics company Evogene (Rehovet) has amended its remaining work plan under its collaboration with Bayer CropScience. The two companies agreed a five-year research collaboration in December 2010 focusing on improving wheat yields, drought tolerance and fertiliser use efficiency (Agrow No 606, p 27). Evogene will shift from discovery of additional genes and single nucleotide polymorphisms to discovery of novel genomic promoters. It will seek to identify tens of promoters that will enhance the probability of success of genes in Bayer’s wheat pipeline. Under the collaboration to date, Evogene has utilised its Athlete computational discovery capabilities to discover and provide Bayer with a large number of candidate genes for potential continued development in Bayer’s wheat pipeline and commercialisation under previously agreed milestone payments and royalty bearing licences from Evogene. “The amendment reflects a growing realisation in the industry that the efficacy of a seed trait depends not only on the presence of the gene of interest, but on its optimisation with other factors including how the gene is expressed in the plant," says Evogene president and CEO Ofer Haviv.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts